About this trial
Though the application of thoracic endovascular aortic repair (TEVAR) for treatment of aortic pathology is expanding, there remains a gap in the literature examining how intraoperative "reduction or elimination of aortic impulse" (REAI) techniques, in particular the use of right atrial occlusion, may impact patient important clinical outcomes. This study aims to provide prospective data from a large cohort of TEVAR patients to explore clinical outcomes following TEVAR procedures and, specifically, whether right atrial occlusion has significant impact on clinical outcomes, as compared to other REAI techniques. The results from this study may inform future perioperative TEVAR practices and improve TEVAR patient outcomes.
Eligibility criteria
Qualifiers
age 18 years or older
thoracic endovascular aortic repair
right atrial balloon occlusion for reduction or elimination of aortic impulse
endograft deployment in landing zones 0-3
Disqualifiers
age 18 years or younger
non-thoracic endovascular aortic repair
reduction or elimination of aortic impulse using technique other than right atrial balloon occlusion
endograft deployment in landing zones 4 and beyond
Trial design
Treatments tested in this trial
- Right atrial balloon occlusion
- Non right atrial balloon occlusion